Development of a Novel Proteomic Approach for the Detection of Transitional Cell Carcinoma of the Bladder in Urine
- 30 April 2001
- journal article
- Published by Elsevier BV in The American Journal of Pathology
- Vol. 158 (4), 1491-1502
- https://doi.org/10.1016/s0002-9440(10)64100-4
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- NEURAL NETWORK ANALYSIS OF CLINICOPATHOLOGICAL AND MOLECULAR MARKERS IN BLADDER CANCERJournal of Urology, 2000
- Proteinchip® surface enhanced laser desorption/ionization (SELDI) mass spectrometry: a novel protein biochip technology for detection of prostate cancer biomarkers in complex protein mixturesProstate Cancer and Prostatic Diseases, 1999
- Urine cytology, tumour markers and bladder cancerBritish Journal of Urology, 1998
- Bactericidal Domain of Lactoferrin: Detection, Quantitation, and Characterization of Lactoferricin in Serum by SELDI Affinity Mass SpectrometryBiochemical and Biophysical Research Communications, 1998
- A Multicenter Trial Evaluation of the Fibrin/Fibrinogen Degradation Products Test for Detection and Monitoring of Bladder CancerJournal of Urology, 1997
- A Multicenter Trial Evaluation of the Fibrin/Fibrinogen Degradation Products Test for Detection and Monitoring of Bladder CancerJournal of Urology, 1997
- Widespread expression of beta‐defensin hBD‐1 in human secretory glands and epithelial cellsFEBS Letters, 1996
- Use of a New Tumor Marker, Urinary NMP22, in the Detection of Occult or Rapidly Recurring Transitional Cell Carcinoma of the Urinary Tract Following Surgical TreatmentJournal of Urology, 1996
- Towards a Comprehensive Database of Proteins From the Urine of Patients With Bladder CancerJournal of Urology, 1996
- Enteric defensins: antibiotic peptide components of intestinal host defense.The Journal of cell biology, 1992